Name: ORGANON & CO (OGN) Stock
Brand: ORGANON & CO
Rating: 3.5 (3 reviews)

OGN Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Zacks Investment Research

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

a month ago - By: Benzinga

Organon Analysts Cut Their Forecasts Following Q3 Results

a month ago - By: Benzinga

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

12 days ago - By: Organon & Co.

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference

19 days ago - By: Zacks Investment Research

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

20 days ago - By: Organon & Co.

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

23 days ago - By: Kahn Swick & Foti, LLC

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

a month ago - By: Zacks Investment Research

Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

a month ago - By: Zacks Investment Research - Mentions: CODX

Organon (OGN) Q3 Earnings and Revenues Beat Estimates

a month ago - By: Organon & Co.

Organon Reports Results for the Third Quarter Ended September 30, 2025

a month ago - By: Organon & Co.

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

a month ago - By: Kahn Swick & Foti, LLC

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

a month ago - By: Organon & Co.

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

a month ago - By: Organon & Co.

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

a month ago - By: Kahn Swick & Foti, LLC

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

a month ago - By: Stocktwits - Mentions: AVUS EAOR

ORGANON & CO (OGN) Stock News

OGN Latest News, Press Relases and Analysis

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Organon Analysts Cut Their Forecasts Following Q3 Results

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Q3 Earnings and Revenues Beat Estimates

Organon Reports Results for the Third Quarter Ended September 30, 2025

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices